SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?


To: Bluegreen who wrote (1113)11/13/2001 10:01:54 AM
From: aknahow  Read Replies (1) | Respond to of 1475
 
Rebound can be eliminated with ease. BTRN should just use the definition found on the Biogen web site. The psoriasis must be WORSE than baseline when treatment began. And for good measure throw in the Biogen caveat that subjects must require hospitalization before a return of the psoriasis is considered rebound.